Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
100 studies found for:    Lupus AND (woman OR women OR female)
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Prasterone (GL701)
2 Unknown  To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids
Condition: Lupus
Intervention: Drug: Prasterone (GL701)
3 Completed Effect of Pioglitazone on Endothelial Function in Premenopausal Women With Uncomplicated Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: pioglitazone;   Drug: placebo
4 Terminated
Has Results
Effect of Simvastatin on Endothelial Function in Premenopausal Women With Systemic Lupus Erythematosus (0733-271)(TERMINATED)
Condition: Systemic Lupus Erythematosus
Interventions: Drug: simvastatin;   Drug: Comparator: Placebo
5 Completed Insulin Resistance and Atherosclerosis in Women With Lupus
Conditions: Systemic Lupus Erythematosus;   Insulin Resistance;   Atherosclerosis
Intervention:
6 Completed A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE)
Condition: Lupus Erythematosus
Interventions: Drug: ABT-199;   Other: Placebo
7 Withdrawn Pharmacodynamics Assessment Study After Single Subcutaneous Dose Of SAR113244 Versus Placebo In Lupus Male And Female Patients
Condition: Systemic Lupus Erythematosus
Interventions: Drug: SAR113244;   Drug: placebo
8 Completed Multiple Ascending Dose Study To Assess The Safety Profile Of SAR113244 Versus Placebo In Lupus Male And Female Patients
Condition: Systemic Lupus Erythematosus
Interventions: Drug: SAR113244;   Drug: placebo
9 Unknown  Estrogen and Gender Biased Autoimmunity
Condition: Systemic Lupus Erythematosus
Intervention: Other: Peripheral lab draws
10 Completed Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)
Conditions: Systemic Lupus Erythematosus;   Lupus
Interventions: Drug: pravastatin;   Drug: aspirin;   Drug: ramipril;   Drug: Vitamins: B6, B12, and folate;   Behavioral: heart health educational program
11 Completed Immunogenicity and Safety of HPV Vaccine Gardasil in Young Women
Condition: Systemic Lupus Erythematosus
Intervention: Biological: Gardasil
12 Completed Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptors
Condition: Systemic Lupus Erythematosus
Intervention: Drug: atorvastatin
13 Completed Psychoeducational Approach to Improve Health in Lupus
Condition: Systemic Lupus Erythematosus
Interventions: Procedure: Counseling intervention;   Device: Informational film
14 Completed Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Dehydroepiandrosterone (DHEA)
15 Completed Effect of Hormone Replacement Therapy on Lupus Activity
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Conjugated equine estrogens 0.625 mg/d + MPA 5 mg/d/10d
16 Completed Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: estradiol;   Drug: ethinyl estradiol;   Drug: medroxyprogesterone;   Drug: norethindrone
17 Completed Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: dehydroepiandrosterone
18 Completed Epidemiologic Study of Reproductive Outcome in Women With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention:
19 Completed Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Mild to Moderate Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: dehydroepiandrosterone
20 Completed Analyzing the Association of Gene Variants With Increased Risk of Coronary Heart Disease in Women With Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.